| 000 | 01727pam a2200313 i 4500 | ||
|---|---|---|---|
| 999 |
_c2105 _d2105 |
||
| 001 | 4435505 | ||
| 005 | 20190718131521.0 | ||
| 008 | 941229s1995 nyua b 001 0 eng | ||
| 020 | _a0824793781 (hbk. : acidfree paper) | ||
| 040 |
_aDLC _cDLC _dDLC _erda |
||
| 082 | 0 | 0 |
_a615.7 _220 _bP |
| 245 | 0 | 0 |
_aPharmacokinetics : _bregulatory, industrial, academic perspectives / _cedited by Peter G. Welling, Francis L.S. Tse. |
| 250 | _aSecond edition. | ||
| 264 | 1 |
_aNew York : _bM. Dekker, _cc1995. |
|
| 300 |
_axi, 512 pages. : _bIllustrations ; _c23 cm |
||
| 336 |
_2rdacontent _atext |
||
| 337 |
_2rdamedia _aunmediated |
||
| 338 |
_2rdacarrier _avolume |
||
| 440 | 0 |
_aDrugs and the pharmaceutical sciences ; _vv. 67 _98591 |
|
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | _aaPharmacokinetics in drug discovery and development: nonclinical studies / Francis L.S. Tse -- Pharmacokinetics in drug discovery and development: clinical studies / Horst F. Schran, James M. Jaffe -- Population pharmacokinetics and pharmacodynamics / Jaap W. Mandema -- Bioavailability and bioequivalence of oral controlled-release products: a regulatory perspective / Henry J. Malinowski, James D. Henderson -- Statistical considerations for bioavailability/bioequivalence studies / Lianng Yuh. | ||
| 650 | 0 | _aPharmacokinetics. | |
| 700 | 1 |
_aWelling, Peter G., _98593 _eeditor. |
|
| 700 | 1 |
_aTse, Francis L. S. _98594 _eeditor. _d1952- |
|
| 856 | 4 | 2 |
_3Publisher description _uhttp://www.loc.gov/catdir/enhancements/fy0647/94047123-d.html |
| 906 |
_a7 _bcbc _corignew _d1 _eocip _f19 _gy-gencatlg |
||
| 942 |
_2ddc _cBK |
||